Supernus Pharmaceuticals Earnings
NASDAQ: SUPNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$0.66
Supernus Pharmaceuticals earnings summary
Supernus Pharmaceuticals is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $0.66. In its most recent report on Aug 3, 2026 (Q2 2026), SUPN posted EPS of $-1.01. Revenue for the quarter was $219.1 million.
Quarterly EPS is down 352.5% from the same quarter a year earlier. Across the last 16 reports, SUPN shares moved an average of 3.4% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
SUPN earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 3, 2026 | — | $-1.01 | — | +1.3% |
| May 5, 2026 | — | $-0.04 | — | -4.1% |
| Mar 2, 2026 | — | $-0.07 | — | -7.4% |
| Nov 6, 2025 | — | $-0.80 | — | -2.2% |
| Aug 5, 2025 | — | $0.40 | — | +3.5% |
| May 6, 2025 | — | $-0.21 | — | +5.5% |
| Feb 25, 2025 | — | $0.27 | — | +0.0% |
| Nov 4, 2024 | — | $0.69 | — | -2.8% |
| Aug 6, 2024 | — | $0.36 | — | +7.6% |
| May 8, 2024 | — | $0.00 | — | +0.5% |
| Nov 8, 2023 | — | $-0.29 | — | +2.9% |
| Aug 8, 2023 | — | $-0.02 | — | -2.9% |
| May 9, 2023 | — | $0.29 | — | +3.4% |
| Mar 9, 2023 | — | $0.44 | — | -0.1% |
| Nov 9, 2022 | — | $0.03 | — | -1.4% |
| Aug 8, 2022 | — | $0.14 | — | +8.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.